FedEx Aktie News

FedEx trades at a forward PE of 13.1, about half that of the S&P 500, offering significant value in a pricey market. FDX is executing on cost savings, margin expansion, and Network 2.0, driving profitability despite trade headwinds and near-term challenges. Management guides for 5% revenue growth, $1B in cost savings, and a Freight business spin-off, positioning FDX for long-term shareholder va...

Bio-Rad Laboratories was a positive contributor after the company reported steadier earnings than the market expected. PVH also remains our largest share repurchaser for the year after buying a teens percentage of shares outstanding at great prices. Rayonier was an immediate contributor.

FedEx is reiterated at a buy rating, supported by signs of business recovery and attractive valuation. Volume and yield metrics are improving, with top-line growth at multi-year highs, indicating demand has likely bottomed for FDX. Near-term profitability may face pressure, but strategic priorities in healthcare and SMB segments support FDX's long-term growth outlook.

With support from the Alcon Foundation, FedEx, and OMEGA, the Orbis Flying Eye Hospital makes its fourth trip to Ghana for a three-week training project in Accra and Kumasi. ACCRA, Ghana, Oct. 13, 2025 /PRNewswire/ -- Global eye care nonprofit Orbis International announces the start of a training project today in Ghana on board the  Orbis Flying Eye Hospital , the world's only fully accredited ...

Shares of FedEx Corp. stumbled at the opening bell Wednesday amid concerns that slower freight demand could weigh on the shipping giant's earnings.

FedEx Corp  (NYSE:FDX) stock is down 2% to trade at $237.44 at last check, after a downgrade from J.P.

Wednesday, JPMorgan analyst Brian Ossenbeck downgraded FedEx shares to Hold from Buy. His price target went to $274 from $284 a share.

Amid a pricey market, Evercore wanted to find stocks that are less pricey but have staying power. Here's how they did it and what they found.